Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies

Stopped early · Phase 1

Conditions studied: Non-small Cell Lung Cancer, Small Cell Lung Cancer, Carcinoid, Thymic Cancer, Lung Cancer

In brief

The goal of this clinical research study is to study the safety of giving larger daily doses of proton radiation therapy than the standard dose levels given to treat lung cancer. Researchers want to find the highest daily dose of proton radiation that can be given without having to stop therapy due to side effects.

Key facts

Study ID

NCT01165658

Run by

M.D. Anderson Cancer Center

People needed

30

Starts

2010-07-16

Expected to finish

2016-07-19

Last updated by the study team

2020-01-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Histologically or cytologically documented NSCLC, SCLC, thymic tumors, or carcinoid tumors
• Patients not receiving concurrent chemotherapy
• Patients that are eligible for concurrent treatment with biologic agents (epidermal growth factor receptor [EGFR] or vascular endothelial growth factor [VEGF] inhibitors) will be eligible for the study.

You may not qualify if…

• Prior radiotherapy to the chest
• Life expectancy <6 months
• Pregnancy

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.